Stuart Henderson

Stuart Henderson was appointed to Oxford Biomedica’s Board as a Non-Executive Director and Chair of the Audit Committee in June 2016. He became Deputy Chair and Senior Independent Director in June 2020. Previously, Mr. Henderson was a partner at Deloitte, where he was Head of European Healthcare and Life Sciences. Prior to this, he was a Partner at Arthur Andersen. Mr. Henderson has extensive audit and transaction experience and has worked with life sciences businesses for 35 years. Mr. Henderson is a former Director of the Babraham Institute and Norwich Research Partners LLP and a Non-Executive Director at OneNucleus (the Life Sciences trade body for Cambridge and London), Biocity Group Limited and Cell Therapy Catapult Limited.

Committee membership

• Audit Committee (Chair)
• Remuneration Committee
• Nomination Committee